Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
AADvac1 Axon peptide 108 conjugated to KLH Alzheimer's Disease (Phase 2), Progressive Nonfluent Aphasia (Phase 1) Axon Neuroscience SE Tau Immunotherapy (active)
ABvac40 Alzheimer's Disease (Phase 2) Araclon Biotech Amyloid-Related Immunotherapy (active)
ACI-24 ACI-24.060,
Pal1-15 acetate salt
Alzheimer's Disease (Phase 2), Down's Syndrome (Phase 2) AC Immune SA Amyloid-Related Immunotherapy (active)
ACI-35 VAC20121,
JNJ-64042056
Alzheimer's Disease (Phase 2/3) AC Immune SA, Janssen Tau Immunotherapy (active)
ACI-7104.056 ACI-7104,
Affitope PD01A,
PD03A
Parkinson's Disease (Phase 2), Multiple System Atrophy (Phase 1) AC Immune SA, AFFiRiS AG alpha-synuclein Immunotherapy (active)
Affitope AD02 Alzheimer's Disease (Discontinued) AFFiRiS AG Amyloid-Related Immunotherapy (active)
ALZ-101 Alzheimer's Disease (Phase 1) Alzinova AB Amyloid-Related Immunotherapy (active)
Amilomotide CAD106 Alzheimer's Disease (Inactive) Novartis Pharmaceuticals Corporation Amyloid-Related Immunotherapy (active) None
AN-1792 AIP 001 Alzheimer's Disease (Discontinued) Janssen, Pfizer Amyloid-Related Immunotherapy (active) None
AV-1959D AV-1959 Alzheimer's Disease (Phase 1) Amyloid-Related Immunotherapy (active)
CpG 1018® CpG oligodeoxynucleotides,
CpG ODN
Alzheimer's Disease (Phase 1) Dynavax Technologies Amyloid-Related, Inflammation Immunotherapy (active), DNA/RNA-based
GV1001 RIAVAXTM, Tertomotide Alzheimer's Disease (Phase 3) GemVax & KAEL Bio Other Immunotherapy (active) Pancreatic cancer (Korea)
Lu AF20513 Alzheimer's Disease (Discontinued) Lundbeck, Otsuka Pharmaceutical Co., Ltd. Amyloid-Related Immunotherapy (active)
Protollin Alzheimer's Disease (Phase 1) I-MAB Biopharma Co., Ltd., Jiangsu Nhwa Pharmaceutical Co., Ltd Inflammation Immunotherapy (active)
UB-311 Alzheimer's Disease (Phase 2) United Neuroscience, Vaxxinity Amyloid-Related Immunotherapy (active)
UB-312 Parkinson's Disease (Phase 2) United Neuroscience, Vaxxinity alpha-synuclein Immunotherapy (active)
Vanutide cridificar ACC-001,
PF-05236806
Alzheimer's Disease (Discontinued) Janssen Amyloid-Related Immunotherapy (active) None